1
|
Lambert S, Thébault A, Rossi S, Marchand P, Petit E, Toïgo C, Gilot-Fromont E. Targeted strategies for the management of wildlife diseases: the case of brucellosis in Alpine ibex. Vet Res 2021; 52:116. [PMID: 34521471 PMCID: PMC8439036 DOI: 10.1186/s13567-021-00984-0] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2020] [Accepted: 07/12/2021] [Indexed: 11/10/2022] Open
Abstract
The management of infectious diseases in wildlife reservoirs is challenging and faces several limitations. However, detailed knowledge of host-pathogen systems often reveal heterogeneity among the hosts' contribution to transmission. Management strategies targeting specific classes of individuals and/or areas, having a particular role in transmission, could be more effective and more acceptable than population-wide interventions. In the wild population of Alpine ibex (Capra ibex-a protected species) of the Bargy massif (French Alps), females transmit brucellosis (Brucella melitensis) infection in ~90% of cases, and most transmissions occur in the central spatial units ("core area"). Therefore, we expanded an individual-based model, developed in a previous study, to test whether strategies targeting females or the core area, or both, would be more effective. We simulated the relative efficacy of realistic strategies for the studied population, combining test-and-remove (euthanasia of captured animals with seropositive test results) and partial culling of unmarked animals. Targeting females or the core area was more effective than untargeted management options, and strategies targeting both were even more effective. Interestingly, the number of ibex euthanized and culled in targeted strategies were lower than in untargeted ones, thus decreasing the conservation costs while increasing the sanitary benefits. Although there was no silver bullet for the management of brucellosis in the studied population, targeted strategies offered a wide range of promising refinements to classical sanitary measures. We therefore encourage to look for heterogeneity in other wildlife diseases and to evaluate potential strategies for improving management in terms of efficacy but also acceptability.
Collapse
Affiliation(s)
- Sébastien Lambert
- Laboratoire de Biométrie et Biologie Évolutive UMR 5558, CNRS, Université Lyon 1, Université de Lyon, Villeurbanne, France. .,Department of Pathobiology and Population Sciences, Royal Veterinary College, University of London, Hatfield, UK.
| | - Anne Thébault
- Direction de l'évaluation des Risques, Agence Nationale de Sécurité Sanitaire, de l'Alimentation, de l'Environnement et du Travail (Anses), Maisons-Alfort, France
| | - Sophie Rossi
- Unité Sanitaire de La Faune, Office Français de la Biodiversité (OFB), Gap, France
| | - Pascal Marchand
- Unité Ongulés Sauvages, Office Français de la Biodiversité (OFB), Juvignac, France
| | - Elodie Petit
- Unité Sanitaire de La Faune, Office Français de la Biodiversité (OFB), Sévrier, France.,Laboratoire de Biométrie et Biologie Évolutive UMR 5558, CNRS, VetAgro Sup, Université de Lyon, Villeurbanne, France
| | - Carole Toïgo
- Unité Ongulés Sauvages, Office Français de La Biodiversité (OFB), Gières, France
| | - Emmanuelle Gilot-Fromont
- Laboratoire de Biométrie et Biologie Évolutive UMR 5558, CNRS, VetAgro Sup, Université de Lyon, Villeurbanne, France
| |
Collapse
|
2
|
An individual-based model to assess the spatial and individual heterogeneity of Brucella melitensis transmission in Alpine ibex. Ecol Modell 2020. [DOI: 10.1016/j.ecolmodel.2020.109009] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
3
|
Sanchez JN, Hudgens BR. Vaccination and monitoring strategies for epidemic prevention and detection in the Channel Island fox (Urocyon littoralis). PLoS One 2020; 15:e0232705. [PMID: 32421723 PMCID: PMC7233584 DOI: 10.1371/journal.pone.0232705] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2019] [Accepted: 04/21/2020] [Indexed: 11/19/2022] Open
Abstract
Disease transmission and epidemic prevention are top conservation concerns for wildlife managers, especially for small, isolated populations. Previous studies have shown that the course of an epidemic within a heterogeneous host population is strongly influenced by whether pathogens are introduced to regions of relatively high or low host densities. This raises the question of how disease monitoring and vaccination programs are influenced by spatial heterogeneity in host distributions. We addressed this question by modeling vaccination and monitoring strategies for the Channel Island fox (Urocyon littoralis), which has a history of substantial population decline due to introduced disease. We simulated various strategies to detect and prevent epidemics of rabies and canine distemper using a spatially explicit model, which was parameterized from field studies. Increasing sentinel monitoring frequency, and to a lesser degree, the number of monitored sentinels from 50 to 150 radio collared animals, reduced the time to epidemic detection and percentage of the fox population infected at the time of detection for both pathogens. Fox density at the location of pathogen introduction had little influence on the time to detection, but a large influence on how many foxes had become infected by the detection day, especially when sentinels were monitored relatively infrequently. The efficacy of different vaccination strategies was heavily influenced by local host density at the site of pathogen entry. Generally, creating a vaccine firewall far away from the site of pathogen entry was the least effective strategy. A firewall close to the site of pathogen entry was generally more effective than a random distribution of vaccinated animals when pathogens entered regions of high host density, but not when pathogens entered regions of low host density. These results highlight the importance of considering host densities at likely locations of pathogen invasion when designing disease management plans.
Collapse
Affiliation(s)
- Jessica N. Sanchez
- Institute for Wildlife Studies, Arcata, California, United States of America
| | - Brian R. Hudgens
- Institute for Wildlife Studies, Arcata, California, United States of America
| |
Collapse
|
4
|
Nepomuceno EG, Barbosa AM, Silva MX, Perc M. Individual-based modelling and control of bovine brucellosis. ROYAL SOCIETY OPEN SCIENCE 2018; 5:180200. [PMID: 29892455 PMCID: PMC5990817 DOI: 10.1098/rsos.180200] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 02/06/2018] [Accepted: 03/26/2018] [Indexed: 06/08/2023]
Abstract
We present a theoretical approach to control bovine brucellosis. We have used individual-based modelling, which is a network-type alternative to compartmental models. Our model thus considers heterogeneous populations, and spatial aspects such as migration among herds and control actions described as pulse interventions are also easily implemented. We show that individual-based modelling reproduces the mean field behaviour of an equivalent compartmental model. Details of this process, as well as flowcharts, are provided to facilitate the reproduction of the presented results. We further investigate three numerical examples using real parameters of herds in the São Paulo state of Brazil, in scenarios which explore eradication, continuous and pulsed vaccination and meta-population effects. The obtained results are in good agreement with the expected behaviour of this disease, which ultimately showcases the effectiveness of our theory.
Collapse
Affiliation(s)
- Erivelton G. Nepomuceno
- Control and Modelling Group (GCOM), Department of Electrical Engineering, Federal University of São João del-Rei, São João del Rei, Brazil
| | - Alípio M. Barbosa
- Department of Electrical Engineering, Centro Universitário Newton Paiva, Belo Horizonte, Brazil
| | - Marcos X. Silva
- Epidemiological Laboratory, Department of Preventive Veterinary Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil
| | - Matjaž Perc
- Faculty of Natural Sciences and Mathematics, University of Maribor, Koroška cesta 160, 2000 Maribor, Slovenia
- CAMTP—Center for Applied Mathematics and Theoretical Physics, University of Maribor, Mladinska 3, 2000 Maribor, Slovenia
- Complexity Science Hub, Josefstädterstraße 39, 1080 Vienna, Austria
| |
Collapse
|
5
|
Current Status of Rift Valley Fever Vaccine Development. Vaccines (Basel) 2017; 5:vaccines5030029. [PMID: 28925970 PMCID: PMC5620560 DOI: 10.3390/vaccines5030029] [Citation(s) in RCA: 80] [Impact Index Per Article: 11.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2017] [Revised: 09/16/2017] [Accepted: 09/18/2017] [Indexed: 01/08/2023] Open
Abstract
Rift Valley Fever (RVF) is a mosquito-borne zoonotic disease that presents a substantial threat to human and public health. It is caused by Rift Valley fever phlebovirus (RVFV), which belongs to the genus Phlebovirus and the family Phenuiviridae within the order Bunyavirales. The wide distribution of competent vectors in non-endemic areas coupled with global climate change poses a significant threat of the transboundary spread of RVFV. In the last decade, an improved understanding of the molecular biology of RVFV has facilitated significant progress in the development of novel vaccines, including DIVA (differentiating infected from vaccinated animals) vaccines. Despite these advances, there is no fully licensed vaccine for veterinary or human use available in non-endemic countries, whereas in endemic countries, there is no clear policy or practice of routine/strategic livestock vaccinations as a preventive or mitigating strategy against potential RVF disease outbreaks. The purpose of this review was to provide an update on the status of RVF vaccine development and provide perspectives on the best strategies for disease control. Herein, we argue that the routine or strategic vaccination of livestock could be the best control approach for preventing the outbreak and spread of future disease.
Collapse
|
6
|
Fatima S, Khan I, Nasir A, Younus M, Saqib M, Melzer F, Neubauer H, El-Adawy H. Serological, molecular detection and potential risk factors associated with camel brucellosis in Pakistan. Trop Anim Health Prod 2016; 48:1711-1718. [PMID: 27677292 DOI: 10.1007/s11250-016-1148-9] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2016] [Accepted: 09/06/2016] [Indexed: 10/20/2022]
Abstract
Brucellosis is one of the most important zoonoses in developing countries and was considered the most widespread zoonosis in the world. Brucellosis was reported in camels and has been reported from all camel-keeping countries.The present study was performed in three districts (Jhang, Chiniot, and Bhakkar) of Punjab province of Pakistan. A total of 200 camel (Camelus bactrianus) sera were collected using random and multistage cluster sampling from different areas. Fifty samples were collected from one organized governmental farm. One hundred fifty samples were collected randomly from nomadic/pastoral production systems. All sera were tested with Rose Bengal plate agglutination test (RBPT) and confirmed by ELISA. Genomic DNA was extracted from all serum samples and tested by real-time PCR. Various potential risk factors (season, rearing with other animals, and abortion or orchitis history) recorded through questionnaires were statistically analyzed by Chi-square test.In total, 5 % of investigated sera were positive by RBPT. Only 2 % of the camel sera were CELISA positive. Brucella abortus DNA was detected in 1.5 % of the investigated animals. Season, rearing of camels with other ruminants, abortion, and orchitis history were found to be statistically significant (p < 0.05) disease for determinants.Camel brucellosis is a zoonotic disease in the Pakistani Punjab with various risk factors maintaining and perpetuating its spread. Therefore, there is a need for implementing control measures and raising public health awareness in prevention of brucellosis in Pakistan.
Collapse
Affiliation(s)
- Sana Fatima
- Section of Epidemiology and Public Health, College of Veterinary and Animal Sciences, Jhang, Pakistan
| | - Iahtasham Khan
- Section of Epidemiology and Public Health, College of Veterinary and Animal Sciences, Jhang, Pakistan
| | - Amar Nasir
- Section of Medicine, College of Veterinary and Animal Sciences, Jhang, Pakistan
| | - Muhammad Younus
- Department of Pathobiology, College of Veterinary and Animal Sciences, Jhang, Pakistan
| | - Muhammad Saqib
- Department of Clinical Medicine and Surgery, University of Agriculture, Faisalabad, Pakistan
| | - Falk Melzer
- Friedrich-Loeffler-Institut, Institute of bacterial infections and zoonoses, Naumburger Str. 96a, 07743, Jena, Germany
| | - Heinrich Neubauer
- Friedrich-Loeffler-Institut, Institute of bacterial infections and zoonoses, Naumburger Str. 96a, 07743, Jena, Germany
| | - Hosny El-Adawy
- Friedrich-Loeffler-Institut, Institute of bacterial infections and zoonoses, Naumburger Str. 96a, 07743, Jena, Germany. .,Faculty of Veterinary Medicine, Kafrelsheikh University, 335516, Kafrelsheikh, Egypt.
| |
Collapse
|
7
|
Vaccination with a ΔnorD ΔznuA Brucella abortus mutant confers potent protection against virulent challenge. Vaccine 2016; 34:5290-5297. [PMID: 27639282 DOI: 10.1016/j.vaccine.2016.09.004] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2016] [Revised: 09/01/2016] [Accepted: 09/02/2016] [Indexed: 12/17/2022]
Abstract
There remains a need for an improved livestock vaccine for brucellosis since conventional vaccines are only ∼70% efficacious, making some vaccinated animals susceptible to Brucella infections. To address this void, a vaccine capable of evoking protective immunity, while still being sufficiently attenuated to produce minimal disease, is sought. In this pursuit, the ΔnorD ΔznuA B. abortus-lacZ (termed as znBAZ) was developed to be devoid of functional norD and znuA B. abortus genes, and to contain the lacZ as a marker gene. The results show that znBAZ is highly attenuated in mouse and human macrophages, and completely cleared from mouse spleens within eight weeks post-vaccination. Producing less splenic inflammation, znBAZ is significantly more protective than the conventional RB51 vaccine by more than four orders of magnitude. Vaccination with znBAZ elicits elevated numbers of IFN-γ+, TNF-α+, and polyfunctional IFN-γ+ TNF-α+ CD4+ and CD8+ T cells in contrast to RB51-vaccinated mice, which show reduced numbers of proinflammatory cytokine-producing T cells. These results demonstrate that znBAZ is a highly efficacious vaccine candidate capable of eliciting diverse T cell subsets that confer protection against parenteral challenge with virulent, wild-type B. abortus.
Collapse
|
8
|
|
9
|
Hobbs NT, Geremia C, Treanor J, Wallen R, White PJ, Hooten MB, Rhyan JC. State-space modeling to support management of brucellosis in the Yellowstone bison population. ECOL MONOGR 2015. [DOI: 10.1890/14-1413.1] [Citation(s) in RCA: 36] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|
10
|
TUBERCULOSIS AND BRUCELLOSIS IN WOOD BISON (BISON BISON ATHABASCAE) IN NORTHERN CANADA: A RENEWED NEED TO DEVELOP OPTIONS FOR FUTURE MANAGEMENT. J Wildl Dis 2015; 51:543-54. [DOI: 10.7589/2014-06-167] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
11
|
Jackson DS, Nydam DV, Altier C. Prevalence and risk factors for brucellosis in domestic yak Bos grunniens and their herders in a transhumant pastoralist system of Dolpo, Nepal. Prev Vet Med 2014; 113:47-58. [DOI: 10.1016/j.prevetmed.2013.09.016] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
12
|
Monath TP. Vaccines against diseases transmitted from animals to humans: a one health paradigm. Vaccine 2013; 31:5321-38. [PMID: 24060567 PMCID: PMC7130581 DOI: 10.1016/j.vaccine.2013.09.029] [Citation(s) in RCA: 55] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2013] [Revised: 09/08/2013] [Accepted: 09/16/2013] [Indexed: 10/28/2022]
Abstract
This review focuses on the immunization of animals as a means of preventing human diseases (zoonoses). Three frameworks for the use of vaccines in this context are described, and examples are provided of successes and failures. Framework I vaccines are used for protection of humans and economically valuable animals, where neither plays a role in the transmission cycle. The benefit of collaborations between animal health and human health industries and regulators in developing such products is discussed, and one example (West Nile vaccine) of a single product developed for use in animals and humans is described. Framework II vaccines are indicated for domesticated animals as a means of preventing disease in both animals and humans. The agents of concern are transmitted directly or indirectly (e.g. via arthropod vectors) from animals to humans. A number of examples of the use of Framework II vaccines are provided, e.g. against brucellosis, Escherichia coli O157, rabies, Rift Valley fever, Venezuelan equine encephalitis, and Hendra virus. Framework III vaccines are used to immunize wild animals as a means of preventing transmission of disease agents to humans and domesticated animals. Examples are reservoir-targeted, oral bait rabies, Mycobacterium bovis and Lyme disease vaccines. Given the speed and lost cost of veterinary vaccine development, some interventions based on the immunization of animals could lead to rapid and relatively inexpensive advances in public health. Opportunities for vaccine-based approaches to preventing zoonotic and emerging diseases that integrate veterinary and human medicine (the One Health paradigm) are emphasized.
Collapse
Affiliation(s)
- Thomas P Monath
- One Health Initiative Pro Bono Team, United States(1); Austria; PaxVax Inc., United States.
| |
Collapse
|
13
|
YANG X, SKYBERG JA, CAO L, CLAPP B, THORNBURG T, PASCUAL DW. Progress in Brucella vaccine development. FRONTIERS IN BIOLOGY 2013; 8:60-77. [PMID: 23730309 PMCID: PMC3666581 DOI: 10.1007/s11515-012-1196-0] [Citation(s) in RCA: 85] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/24/2011] [Accepted: 01/16/2012] [Indexed: 01/18/2023]
Abstract
Brucella spp. are zoonotic, facultative intracellular pathogens, which cause animal and human disease. Animal disease results in abortion of fetuses; in humans, it manifests flu-like symptoms with an undulant fever, with osteoarthritis as a common complication of infection. Antibiotic regimens for human brucellosis patients may last several months and are not always completely effective. While there are no vaccines for humans, several licensed live Brucella vaccines are available for use in livestock. The performance of these animal vaccines is dependent upon the host species, dose, and route of immunization. Newly engineered live vaccines, lacking well-defined virulence factors, retain low residual virulence, are highly protective, and may someday replace currently used animal vaccines. These also have possible human applications. Moreover, due to their enhanced safety and efficacy in animal models, subunit vaccines for brucellosis show great promise for their application in livestock and humans. This review summarizes the progress of brucellosis vaccine development and presents an overview of candidate vaccines.
Collapse
Affiliation(s)
- Xinghong YANG
- Department of Immunology & Infectious Diseases, Montana State University, Bozeman, MT 59717-3610, USA
| | - Jerod A. SKYBERG
- Department of Immunology & Infectious Diseases, Montana State University, Bozeman, MT 59717-3610, USA
| | - Ling CAO
- Department of Immunology & Infectious Diseases, Montana State University, Bozeman, MT 59717-3610, USA
| | - Beata CLAPP
- Department of Immunology & Infectious Diseases, Montana State University, Bozeman, MT 59717-3610, USA
| | - Theresa THORNBURG
- Department of Immunology & Infectious Diseases, Montana State University, Bozeman, MT 59717-3610, USA
| | - David W. PASCUAL
- Department of Immunology & Infectious Diseases, Montana State University, Bozeman, MT 59717-3610, USA
| |
Collapse
|
14
|
BCG vaccination against tuberculosis in European badgers (Meles meles): A review. Comp Immunol Microbiol Infect Dis 2012; 35:277-87. [DOI: 10.1016/j.cimid.2012.01.009] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2011] [Revised: 01/14/2012] [Accepted: 01/18/2012] [Indexed: 12/22/2022]
|
15
|
Efficacy of dart or booster vaccination with strain RB51 in protecting bison against experimental Brucella abortus challenge. CLINICAL AND VACCINE IMMUNOLOGY : CVI 2012; 19:886-90. [PMID: 22496493 DOI: 10.1128/cvi.00107-12] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
This study characterized the efficacy of the Brucella abortus strain RB51 vaccine in bison when delivered by single intramuscular vaccination (hand RB51), by single pneumatic dart delivery (dart RB51), or as two vaccinations approximately 13 months apart (booster RB51) in comparison to control bison. All bison were challenged intraconjunctivally in midgestation with 10(7) CFU of B. abortus strain 2308 (S2308). Bison were necropsied and sampled within 72 h of abortion or delivery of a live calf. Compared to nonvaccinated bison, bison in the booster RB51 treatment had a reduced (P < 0.05) incidence of abortion, uterine infection, or infection in maternal tissues other than the mammary gland at necropsy. Bison in single-vaccination treatment groups (hand RB51 and dart RB51) did not differ (P > 0.05) from the control group in the incidence of abortion or recovery of S2308 from uterine, mammary, fetal, or maternal tissues at necropsy. Compared to nonvaccinated animals, all RB51 vaccination groups had reduced (P < 0.05) mean colonization or incidence of infection in at least 2 of 4 target tissues, with the booster RB51 group having reduced (P < 0.05) colonization and incidence of infection in all target tissues. Our data suggest that booster vaccination of bison with RB51 enhances protective immunity against Brucella challenge compared to single vaccination with RB51 by hand or by pneumatic dart. Our study also suggests that an initial vaccination of calves followed by booster vaccination as yearlings should be an effective strategy for brucellosis control in bison.
Collapse
|